Cargando…

Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease

BACKGROUND: There is paucity of risk factors on lung function decline among patients with non-tuberculous mycobacteria (NTM) pulmonary disease in literature. METHODS: Patients with NTM pulmonary disease between January 2000 and April 2011 were retrospectively selected. Sixty-eight patients had at le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Meng-Rui, Yang, Ching-Yao, Chang, Kai-Ping, Keng, Li-Ta, Yen, David Hung-Tsang, Wang, Jann-Yuan, Wu, Huey-Dong, Lee, Li-Na, Yu, Chong-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590167/ https://www.ncbi.nlm.nih.gov/pubmed/23483998 http://dx.doi.org/10.1371/journal.pone.0058214

Ejemplares similares

Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study
por: Shu, Chin-Chung, et al.
Publicado: (2010)

Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area
por: Ruan, Sheng-Yuan, et al.
Publicado: (2012)

In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement
por: Shu, Chin-Chung, et al.
Publicado: (2011)

Tuberculous constrictive pericarditis with concurrent active pulmonary tuberculous infection: a case report
por: Liu, Yen-Wen, et al.
Publicado: (2009)

The lung microbiota in Korean patients with non-tuberculous mycobacterial pulmonary disease
por: Kang, Sung-Yoon, et al.
Publicado: (2021)

The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
por: Alkarni, Meyad, et al.
Publicado: (2023)

Pulmonary non-tuberculous mycobacterial infections: current state and future management
por: Chin, Kai Ling, et al.
Publicado: (2019)

Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
por: Kumar, Kartik, et al.
Publicado: (2021)

Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali
por: Kone, B., et al.
Publicado: (2018)

Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China
por: Hu, Chunmei, et al.
Publicado: (2019)

Factors affecting in-hospital mortality of non-tuberculous mycobacterial pulmonary disease
por: Tanaka, Goh, et al.
Publicado: (2021)

Non-Tuberculous Mycobacterial Diseases in Children
por: Meoli, Aniello, et al.
Publicado: (2020)

Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice
por: Wei, Wei, et al.
Publicado: (2022)

Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study
por: Veziris, Nicolas, et al.
Publicado: (2021)

Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease
por: Lee, Chih-Hsin, et al.
Publicado: (2012)

L-Tyrosine Limits Mycobacterial Survival in Tuberculous Granuloma
por: Gao, Yaxian, et al.
Publicado: (2023)

Textbook of tuberculosis & non-tuberculous mycobacterial diseases
por: Kant, Surya
Publicado: (2021)

Comparative chest computed tomography findings of non-tuberculous mycobacterial lung diseases and pulmonary tuberculosis in patients with acid fast bacilli smear-positive sputum
por: Yuan, Mei-Kang, et al.
Publicado: (2014)

Establishing Aspergillus-Specific IgG Cut-Off Level for Chronic Pulmonary Aspergillosis Diagnosis: Multicenter Prospective Cohort Study
por: Lee, Meng-Rui, et al.
Publicado: (2021)

Monocyte-derived macrophages do not explain susceptibility to pulmonary non-tuberculous mycobacterial disease
por: de Jong, Emma, et al.
Publicado: (2012)

Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
por: Lipman, Marc, et al.
Publicado: (2020)

Case studies to illustrate good practice in the management of non-tuberculous mycobacterial pulmonary disease
por: Tiberi, Simon, et al.
Publicado: (2022)

Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases
por: Sharma, Surendra K., et al.
Publicado: (2020)

Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease
por: Pennington, Kelly M., et al.
Publicado: (2021)

The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease
por: Lin, Chou-Han, et al.
Publicado: (2016)

Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis
por: Chung, Kuei-Pin, et al.
Publicado: (2011)

Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011
por: Ringshausen, Felix C, et al.
Publicado: (2013)

British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
por: Haworth, Charles S, et al.
Publicado: (2017)

Non-tuberculous mycobacterial ocular infection masquerading as choroidal tumour – a diagnostic conundrum
por: Yeap, Khy Ching, et al.
Publicado: (2019)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
por: Shaw, Timothy David, et al.
Publicado: (2021)

Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections
por: Dohál, Matúš, et al.
Publicado: (2021)

Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease
por: Ratnatunga, Champa N., et al.
Publicado: (2022)

Non-tuberculous mycobacterial disease associated with Mycobacterium montefiorense in salamanders
por: Komine, Takeshi, et al.
Publicado: (2023)

Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates
por: Ghio, Andrew J., et al.
Publicado: (2019)

Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
por: Liang, Sheng-Kai, et al.
Publicado: (2021)

Challenges of diagnosing and treating non-tuberculous mycobacterial pulmonary disease [NTM-PD]: A case series
por: Chindam, Aditya, et al.
Publicado: (2021)

Non-tuberculous mycobacterial pulmonary disease: Awareness survey of front-desk healthcare workers in Northern Tanzania
por: Maya, Togolani, et al.
Publicado: (2023)

Diagnosis of Non-Tuberculous Mycobacterial Pulmonary Disease by Metagenomic Next-Generation Sequencing on Bronchoalveolar Lavage Fluid
por: Zhang, Xuan, et al.
Publicado: (2023)

The epidemiology, demographics, and comorbidities of pulmonary and extra-pulmonary non-tuberculous mycobacterial infections at a large central Florida Academic Hospital
por: Garcia, Cristina V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g4dai81voat7jnj78srso5qao8